Highlights and Quick Summary
- Interest Debt per Share for the quarter ending September 30, 2022 was $11.5 (a -0.52% decrease compared to previous quarter)
- Year-over-year quarterly Interest Debt per Share decreased by -2.15%
- Annual Interest Debt per Share for 2021 was $11.8 (a 192.63% increase from previous year)
- Annual Interest Debt per Share for 2020 was $4.05 (a 326.03% increase from previous year)
- Annual Interest Debt per Share for 2019 was $0.95 (a 7.59% increase from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Interest Debt per Share of BridgeBio Pharma, Inc.
Most recent Interest Debt per Shareof BBIO including historical data for past 10 years.Interactive Chart of Interest Debt per Share of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Interest Debt per Share for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.0 | $0.0 | $0.0 | – |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2018 | – | – | $0.0 | $0.0 | $0.0 |
| 2017 | – | – | – | – | $0.0 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology